切換帳號

  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 登入

全站搜尋

台灣泌尿科醫學會E-School
  • 登入
  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 到官網
  • Home
  • 到官網
  • Home
知識庫
  • 目錄總覽
  • 文件總覽
  • 最新討論
目錄 / 資料夾
  • 學術活動與演講
    • 年會
      • 2026年會
        • 摘要
      • 2026半年會
        • 摘要
      • 2025年會 (UAA)
        • 摘要
      • 2025半年會
        • 摘要
      • 2024年會
        • 摘要
      • 2024半年會
        • 摘要
      • 2023年會
        • 摘要
      • 2023半年會
        • 摘要
      • 2022年會
        • 摘要
      • 2021年會
        • 摘要
      • 2021半年會
        • 摘要
      • 2020年會
        • 摘要
      • 2020半年會
        • 摘要
      • 2019年會
        • 摘要
      • 2019半年會
        • 摘要
      • 2018年會
        • 摘要
      • 2018半年會
        • 摘要
      • 2017年會
        • 摘要
      • 2017半年會
        • 摘要
      • 2016年會
        • 摘要
      • 2016半年會
        • 摘要
      • 2015年會
        • 摘要
  • 新手指南與FAQ
  1. 知識庫
  2. 熱門媒體

熱門媒體
(
  • 最新
)

熱門媒體

(
  • 最新
)
NDP02: Pathological characteristic of upper urinary tract urothelial carcinoma undetected on Fluorodeoxyglucose positron emission tomography /computed tomography (18F-FDG PET-CT)
2324 觀看
PD03-4: Whole ureter reconstruction using yang-monti ileal ureter reconstruction: Successful treatment of challenging conditions
2323 觀看
MP060: Renal transplantation in patient with cloacal malformations: a rare case report
2322 觀看
MP24: Triptolide suppressed migration and invasion of du145 prostate cancer cells via the critical nf-kappab-dependent pathway
2322 觀看
MP06-02: The senhance robotic system is feasible in oncologic and non-oncologic urologic surgeries: initial experiences and troubleshooting of new system
2322 觀看
(NDP073) Laparoscopic retzius-sparing radicalprostatectomy: A reversed evolution from robotic-assisted radical prostatectomy
2321 觀看
MP002: The comparison of outcomes of robot-assisted and open partial nephrectomy in renal cell carcinoma: A single center experience
2321 觀看
NDP30: The association of matrix metalloproteinase-7 genotypes with the risk of bladder cancer in mid-Taiwanese people
2319 觀看
NDP029: Is maximum urine flow rate of less than 15ml/sec a risk factor of urine retention
2318 觀看
MP005: Xp11.2 translocation renal cell carcinoma - experiences of VGHTC
2317 觀看
MP056: Synthetic Flavonoid WYC0209 Inhibits Urothelial Carcinoma Cell Invasion through Repressing HDGF/c-src Expression and Epithelial‑Mesenchymal Transition
2317 觀看
MP74: Nivolumab in metastatic renal cell carcinoma preliminary report
2317 觀看
PD08-2: Treatment outcome and FGFR alteration rate in unresectable locally advanced or metastatic urothelial cancer in Taiwan
2317 觀看
PD8-2: Urinary biomarkers in patients with detrusor underactivity with and without bladder function recovery
2316 觀看
MP029: The impact of DPP4 overexpression in patients with urothelial carcinoma
2313 觀看
(NDP090) Cholecystectomy is necessary or not about that ketamine absue induces cholestasis with common bile duct dilatation?
2312 觀看
NDP089: Investigation of difference of perception in doctor-patient relationship between hospital and clinic doctor from perspective of multiculturism
2312 觀看
(NDP104) Single port laparoscopy diagnosis & resection of appendicovesical fistula--a case report
2311 觀看
NDP18: Benign prostatic hyperplasia increases the risk of colon cancer: A population-based study
2311 觀看
PD1-2: The evaluation of immunotherapy response for patients with metastasis renal cell carcinoma in Taipei Veterans General Hospital
2310 觀看
NDP17: The predictors for effectiveness of ESWT on patients with chronic pelvic pain syndrome
2310 觀看
NDP07: Distal metastases from prostate cancer: 9-year experience of a single institution
2307 觀看
NDP26: Prostate abscess with extremely rare burkholderia pseudomallei infection: A case report and review of literature
2307 觀看
(NDP027) Cancer-to-cancer metastasis: breast cancer metastasized into renal cell carcinoma—a case report
2306 觀看
  • <
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • >
/ 163
地址:台北市 11051 信義區基隆路一段432號6樓之1, 電話:02-2729-0819, 傳真:02-2729-0864
網址: http://eschool.tua.org.tw,  EMail: eschool@tua.org.tw